###begin article-title 0
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
###xml 52 57 <span type="species:ncbi:9606">Human</span>
The Cell Adhesion Molecule "CAR" and Sialic Acid on Human Erythrocytes Influence Adenovirus In Vivo Biodistribution
###end article-title 0
###begin p 1
Conceived and designed the experiments: ES DH HW MP HLJ JPW SC EJK. Performed the experiments: ES DH HW OB MP CH FM GS HLJ HD SI VK. Analyzed the data: ES DH HW OB MP CH FM GS HLJ HD SI VK SC EJK. Contributed reagents/materials/analysis tools: JPW RF SC EJK. Wrote the paper: VK SC EJK.
###end p 1
###begin p 2
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 975 982 975 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 329 334 <span type="species:ncbi:9606">human</span>
###xml 374 377 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 416 421 <span type="species:ncbi:9606">human</span>
###xml 708 711 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 887 892 <span type="species:ncbi:9606">human</span>
###xml 1338 1343 <span type="species:ncbi:9606">human</span>
Although it has been known for 50 years that adenoviruses (Ads) interact with erythrocytes ex vivo, the molecular and structural basis for this interaction, which has been serendipitously exploited for diagnostic tests, is unknown. In this study, we characterized the interaction between erythrocytes and unrelated Ad serotypes, human 5 (HAd5) and 37 (HAd37), and canine 2 (CAV-2). While these serotypes agglutinate human erythrocytes, they use different receptors, have different tropisms and/or infect different species. Using molecular, biochemical, structural and transgenic animal-based analyses, we found that the primary erythrocyte interaction domain for HAd37 is its sialic acid binding site, while CAV-2 binding depends on at least three factors: electrostatic interactions, sialic acid binding and, unexpectedly, binding to the coxsackievirus and adenovirus receptor (CAR) on human erythrocytes. We show that the presence of CAR on erythrocytes leads to prolonged in vivo blood half-life and significantly reduced liver infection when a CAR-tropic Ad is injected intravenously. This study provides i) a molecular and structural rationale for Ad-erythrocyte interactions, ii) a basis to improve vector-mediated gene transfer and iii) a mechanism that may explain the biodistribution and pathogenic inconsistencies found between human and animal models.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 318 325 318 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 840 847 840 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 522 525 <span type="species:ncbi:10116">rat</span>
###xml 610 616 <span type="species:ncbi:9606">humans</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 721 726 <span type="species:ncbi:9606">human</span>
In most cases, adenoviruses are thought to initially enter the host via contact with epithelial cells and spread within the host via an unknown mechanism. Most adenovirus serotypes use a cell adhesion molecule dubbed "CAR" to attach to cells. To assess, predict and understand adenovirus biology and vectorology, many in vivo studies use mice and monkeys. These animal models have been considered reliable models in the realm of viral pathogenesis and gene transfer. One of the implications of our study suggests that the rat may be a more appropriate model during intravenous adenovirus delivery because like humans, and unlike mice and monkeys, they also express CAR on their erythrocytes. The identification of CAR on human erythrocytes explains a 50-year-old enigma of adenovirus hemagglutination, helps us better understand adenovirus in vivo biology and may open new avenues to understand the role of cell adhesion molecules during erythropoiesis.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 373 376 373 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Cusack1">[1]</xref>
###xml 518 521 518 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Gelderblom1">[2]</xref>
###xml 532 540 532 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 770 773 770 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Zhang1">[3]</xref>
###xml 1210 1213 1210 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Albinsson1">[4]</xref>
###xml 1214 1217 1214 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Soudais1">[5]</xref>
###xml 1068 1073 <span type="species:ncbi:9606">human</span>
###xml 1129 1132 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Adenoviruses (Ads) are nonenveloped double-stranded DNA pathogens that infect all vertebrate classes. To date, all Ads display a characteristic, icosahedral symmetry in which 240 subunits of the trimeric hexon protein form the facets and 12 copies of the penton, comprising the pentameric penton base protein and the externally projecting trimeric fiber, form the vertices [1]. While the stoichiometry of the penton base and hexon is apparently conserved, the fiber can exist as a single or double copy at each vertex [2]. At least in vitro and for most cell types, the fiber mediates the initial attachment to primary receptors, such as the D1 domain of the coxsackievirus and adenovirus receptor (CAR), sialic acids, CD46, and others (for review see Zhang & Bergelson [3]). Interaction with auxiliary receptor(s), in particular some of the dimeric integrins via the Arg-Gly-Asp sequence (an integrin-interacting motif) on the penton base, may induce internalization of some serotypes. However, other auxiliary receptors or mechanism of internalization may exist for human serotypes 40 and 41 (HAd40/41), and canine serotype 2 (CAV-2), which have no identifiable integrin-interacting motif in the penton base [4],[5].
###end p 6
###begin p 7
###xml 346 349 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Lenaerts1">[6]</xref>
###xml 350 353 350 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Hierholzer1">[7]</xref>
###xml 523 530 523 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 579 582 579 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Rosen1">[8]</xref>
###xml 1020 1023 1020 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Norrby1">[9]</xref>
###xml 1024 1028 1024 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Marusyk1">[12]</xref>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 359 364 <span type="species:ncbi:9606">human</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
Greater than 150 Ad serotypes have been isolated. Approximately 50 of these are currently classed as human pathogens that, in most cases, generate subclinical ocular, respiratory and gastrointestinal tract infections. In the immunocompromised host however, lethal HAd infections can spread, via unknown mechanisms, to the kidney, liver and brain [6],[7]. The human Ads (HAds) are divided into subgroups (or species or subgenera) A - F. The triage of the human serotypes into subgroups is based in part on serotype-specific ex vivo erythrocyte cross-linking (or hemagglutination) [8]. The clinical hemagglutination assays use lysates from virus-infected cells to crosslink erythrocytes from a handful of species. This highly heterogeneous lysate contains whole virus particles, empty capsids, penton monomers, penton dodecahedrons, fiber monomers, hexon etc. By using fractionated infected cell lysate, a handful of laboratories found that the multivalent complexes containing fiber were responsible for hemagglutination [9]-[12].
###end p 7
###begin p 8
###xml 165 166 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 387 391 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Chasis1">[13]</xref>
###xml 785 789 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Forrest1">[14]</xref>
###xml 790 794 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-SchwegmannWessels1">[18]</xref>
###xml 964 968 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Rogers1">[19]</xref>
Erythrocyte membranes contain highly sialated glycoproteins and glycolipids. One of the most abundant glycoproteins on erythrocytes is glycophorin A (approximately105 copies/cell). With its high sialic acid content, glycophorin A is the main contributor to the net negative cell-surface charge and is critical for minimizing cell-cell interactions and preventing erythrocyte aggregation [13]. Sialic acid is a collective term for a family of 9-carbon monosaccharides, which are often found as terminal sugar residues on glycans of glycoproteins and glycolipids (usually alpha2-3, -6 or -8 linked). In addition to some HAds, a number of viruses, including orthomyxoviruses, paramyxoviruses, picornaviruses, papovaviruses, coronaviruses, reoviruses and parvoviruses bind to sialic acids [14]-[18]. Possibly because erythrocytes from different species vary in their sialic acid content, the hemagglutination properties of sialic acid-binding viruses may also diverge [19].
###end p 8
###begin p 9
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Mei1">[20]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-PringAkerblom1">[23]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Seiradake1">[24]</xref>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Wu1">[26]</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Burmeister1">[27]</xref>
HAd subgroup D (serotypes 9, 15, 19p and 37) and B:2 (serotypes 11a, 11p and 34a) erythrocyte binding depends on the fiber head and several attempts have been made to define the region(s) responsible [20]-[23]. Among the HAds, serotype 37 is unusual: its fiber head can bind CAR, CD46 and sialic acid, but the virus appears to use only the latter two as functional receptors [24]-[26]. Burmeister et al. found that the sialic acid moiety bound to a basic patch close to the center of the trimeric fiber heads of HAd37 and HAd19p [27]. Interestingly, the putative hemagglutination domain in subgroup D heads partially aligns with the sialyl-lactose binding site, which on the basis of sequence alignments is likely to be conserved in other members of this subgroup. These observations raise the question as to whether Ad-erythrocyte interaction is a consequence of fiber head-sialic acid interaction.
###end p 9
###begin p 10
###xml 264 267 264 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Soudais1">[5]</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Arnberg1">[25]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Wu1">[26]</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Asher1">[28]</xref>
###xml 1063 1070 1063 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 104 107 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 135 138 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 498 501 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 704 707 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 768 773 <span type="species:ncbi:9606">human</span>
###xml 778 781 <span type="species:ncbi:10116">rat</span>
###xml 815 820 <span type="species:ncbi:10090">mouse</span>
###xml 1194 1199 <span type="species:ncbi:9606">human</span>
In this study we initially characterize the erythrocyte binding of unrelated serotypes, HAd5, HAd37 and CAV-2. Although both HAd37 and CAV-2 agglutinate human erythrocytes at low particle-to-cell ratios, they use different receptors (sialic acid and CD46 vs. CAR) [5],[25],[26], have different clinical tropisms (ocular vs. respiratory tract) and infect different species. We found that HAd37-erythrocyte interaction is primarily due to sialic acid binding. We show by structural analysis that the CAV-2 fiber head also contains a sialic acid binding site, but in contrast to HAd37 this site is modestly involved in hemagglutination. Unexpectedly, our biochemical and competition analyses suggested that CAV-2-erythrocyte interactions also depend on binding to CAR on human and rat erythrocytes. Using a transgenic mouse that expresses CAR on erythrocytes [28] we demonstrate that CAR-binding Ads can be sequestered by CAR-expressing erythrocytes, and prevent liver infection. Our study provides a molecular and structural rationale for the 50-year-old enigma of ex vivo Ad-erythrocyte interactions. In addition to the relevance for Ad pathogenesis and vector biology, the expression of CAR by human erythrocytes may shed light on the role of cell adhesion molecules during erythropoiesis.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Hemagglutination assays using Ads
###end title 12
###begin p 13
###xml 174 183 162 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g001">Figure 1A</xref>
###xml 292 301 268 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g001">Figure 1B</xref>
###xml 345 349 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Cichon1">[29]</xref>
###xml 439 448 415 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g001">Figure 1C</xref>
###xml 590 594 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Chiu1">[30]</xref>
###xml 624 628 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Glasgow1">[31]</xref>
###xml 782 797 758 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g001">Figure 1D and E</xref>
###xml 963 971 939 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g001">Figure 1</xref>
###xml 1143 1150 1119 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000277-t001">Table 1</xref>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 210 213 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 374 379 <span type="species:ncbi:9606">human</span>
###xml 483 486 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 618 621 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 669 672 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 775 778 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1076 1079 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1102 1105 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Consistent with previous reports, we found that at a modest physical particle (pp)-to-erythrocyte ratio (approximately130) HAd37 efficiently agglutinates human erythrocytes (Figure 1A). When compared to HAd37, CAV-2 hemagglutinates at approximately20-fold lower ratio (i.e. more efficiently, Figure 1B). In our hands, and consistent with others [29], HAd5 also agglutinated human erythrocytes, but at a higher ratio (>800 pp/erythrocyte) (Figure 1C). To assay the roles of HAd37 and CAV-2 capsid proteins, we incubated erythrocytes with chimeric HAd5 vectors harboring the fiber from HAd37 [30] or the fiber head from CAV-2 [31]. We found that the HAd5-HAd37F and HAd5-CAV-2H hybrid capsids induced agglutination at lower ratios than HAd5 but not quite to those of HAd37 and CAV-2 (Figure 1D and E). Pre-incubating erythrocytes with neuraminidase, which removes sialic acid from their membranes, eliminated agglutination by HAd37 and a HAd5-HAd37F hybrid capsid (Figure 1, right hand column). In contrast, removing sialic acid from erythrocyte membranes only modestly reduced CAV-2 and the hybrid HAd5-CAV-2H agglutination (data summarized in Table 1).
###end p 13
###begin title 14
###xml 36 39 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Hemagglutination assays with HAd37, CAV-2, HAd5 or hybrid capsids.
###end title 14
###begin p 15
###xml 538 547 538 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s004">Figure S4</xref>
###xml 233 236 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 340 343 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 379 382 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Mock-treated (left hand column) or neuraminidase-treated (right hand column) erythrocytes (all wells contain the same number of cells) were incubated with serial dilutions (10-fold vertically and 2-fold horizontally) of A. HAd37; B. CAV-2; C. HAd5; D. HAd5-HAd37F, a hybrid capsid containing the HAd37 fiber on the HAd5 capsid; and E. HAd5-CAV-2H, a hybrid capsid containing the CAV-2 fiber head on the HAd5 capsid. Agglutination is visualized by the lack of erythrocyte sedimentation (no red spot) at the bottom of the conical well (see Figure S4 for graphic description). The pink shaded well is the first well that does not significantly agglutinate. All assays were performed at least three times.
###end p 15
###begin title 16
Virus-induced hemagglutination
###end title 16
###begin p 17
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
The agglutination titer in physical particles-to-erythrocyte (1.5x106 erythrocytes/well).
###end p 17
###begin p 18
High numbers = poor agglutinator.
###end p 18
###begin p 19
infinity = no agglutination
###end p 19
###begin p 20
###xml 38 41 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 240 243 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Together, these data suggest that the CAV-2 fiber head, like in subgroup D and B:2 HAds, is responsible for hemagglutination and that sialic acid binding plays a more significant role in HAd37 binding of human erythrocytes than it does for CAV-2.
###end p 20
###begin p 21
###xml 202 205 202 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Norrby1">[9]</xref>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Burmeister1">[27]</xref>
###xml 471 478 471 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000277-t002">Table 2</xref>
###xml 670 672 670 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 675 684 675 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s001">Figure S1</xref>
###xml 751 752 751 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 789 796 789 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000277-t002">Table 2</xref>
###xml 903 910 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000277-t002">Table 2</xref>
###xml 1038 1042 1038 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;1</sup>
###xml 1062 1063 1062 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1148 1150 1148 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1199 1201 1199 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1175 1178 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1193 1196 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
To mimic the hemagglutination caused by HAd37 fiber head in a virion-like context, we generated a multivalent protein complex similar to the "complete hemagglutinin" described for HAd9 by Norrby et al. [9]. For this purpose HAd3 penton dodecahedra were incubated with chimeric "mini fibers" consisting of HAd3 fiber tail and shaft motifs 1+2 and HAd37 fiber head. In addition, we generated HAd37 fiber heads containing mutations in the sialic acid binding site [27] (see Table 2 for a list of fiber head mutants). The HAd3 penton dodecahedra without a fiber did not cause hemagglutination (data not shown). The dodecahedra containing a wild type HAd37 fiber head (HAd37Hwt) (Figure S1) agglutinated erythrocytes at low protein concentrations (about 104-fold less mass than HAd37 virions) (Table 2). Similar to HAd37, this "complete hemagglutinin" poorly agglutinates neuraminidase-treated erythrocytes (Table 2). The dodecahedra containing a HAd37 fiber with a Lys to Glu mutation at amino acid 345 in the sialic acid binding site (HAd37HSA-1), had at least a 105-fold reduced hemagglutination activity compared to the dodecahedra containing HAd37Hwt. The chimeric wild type CAV-2 fiber head (CAV-2Hwt) did not bind to HAd3 penton dodecahedra, which precluded equivalent experiments.
###end p 21
###begin title 22
Relative hemagglutination titers of capsid subunits (higher numbers = poor agglutinator)
###end title 22
###begin p 23
###xml 78 83 <span type="species:ncbi:9606">human</span>
A relative comparison of protein concentrations that induced agglutination of human erythrocytes.
###end p 23
###begin p 24
Higher numbers = poor agglutinator: Like sample (e.g. dodecahedra vs. dodecahedra, fiber heads vs. fiber heads, or trimeric clusters vs. trimeric clusters) can be compare.
###end p 24
###begin p 25
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
The highest concentration of HAd3 dodecahedra alone or in complex with mini-fibers was 3x10-4 microg/microl.
###end p 25
###begin p 26
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 40 43 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
The highest concentration of His-tagged CAV-2 fiber head constructs was 5x10-4 microg/microl. alpha(2-3,-6,-8 and -9) neuraminidase was used in this assay.
###end p 26
###begin p 27
infinity = no agglutination.
###end p 27
###begin p 28
###xml 168 173 <span type="species:ncbi:9606">human</span>
These data suggest that the HAd37 fiber shaft, hexon and pIX do not play key roles during binding and that the sialic acid binding site is involved in agglutination of human erythrocytes.
###end p 28
###begin title 29
Binding of the fiber heads to erythrocytes and glycophorin
###end title 29
###begin p 30
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 223 225 223 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 227 236 227 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g002">Figure 2A</xref>
###xml 306 311 306 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAR&#8722;1</sup>
###xml 322 327 322 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAR&#8722;2</sup>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Seiradake1">[24]</xref>
###xml 446 450 446 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;1</sup>
###xml 461 465 461 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;2</sup>
###xml 592 601 592 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g002">Figure 2A</xref>
###xml 695 704 695 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g002">Figure 2A</xref>
To assay the binding of recombinant fiber heads, we incubated HAd37Hwt and mutant fiber heads with erythrocytes and then added anti-fiber head antibodies or antiserum. We then quantified attachment by flow cytometry. HAd37Hwt (Figure 2A) and mutants carrying point mutations in the CAR binding site (HAd37HCAR-1 and HAd37HCAR-2, mutation in Glu351 and Ser299, data not shown) [24] bound to erythrocytes in a dose-dependent manner. However, HAd37HSA-1 and HAd37HSA-2 (a Tyr to Ala mutation at amino acid 312), which harbor mutations in the sialic acid binding site, poorly bound erythrocytes (Figure 2A). In addition, all of the HAd37 fiber heads poorly bound neuraminidase-treated erythrocytes (Figure 2A, bottom row and data not shown).
###end p 30
###begin title 31
###xml 47 52 <span type="species:ncbi:9606">human</span>
Binding of wild type and mutant fiber heads to human erythrocytes.
###end title 31
###begin p 32
###xml 327 329 327 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 348 352 348 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;1</sup>
###xml 362 366 362 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;2</sup>
###xml 614 618 614 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;2</sup>
###xml 860 862 860 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1004 1006 1004 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 837 840 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
A. HAd37 fiber head binding to erythrocytes (mock-treated, top panels or neuraminidase-treated, bottom panels) as measured by flow cytometry. The shadowed profile = mock-treated erythrocytes without fiber heads. The line graphs correspond to four 10-fold dilutions (13, 1.3, 0.13 and 0.013 mM) of three HAd37 fiber heads: HAd37wt = wild type, HAd37SA-1 and HAd37SA-2 contain mutations in the HAd37H sialic acid binding domain. The lowest dilution (0.013 mM = the dotted line in the top left panel. The darkest line (furthest to the right in the top left panel) = 13 mM. Except for the modest binding of 13 mM HAd37SA-2 to neuraminidase-treated cells (bottom row middle panel), no other notable binding could be detected and therefore the line profiles overlap or are hidden by the shadowed mock-treated profile. B. Fluorescently-labeled CAV-2 fiber head (CAV2Hwt) binding to mock-treated (left) or neuraminidase-treated (right) erythrocytes as measured by flow cytometry. Three 10-fold dilutions of CAV2Hwt (13, 1.3 and 0.13 mM) covalently labeled with Cy5 were assayed. The shadowed profile = mock-treated erythrocytes without fiber heads. As above the highest concentration of fiber head is in the darkest line profile. All assays were performed at least twice in triplicate.
###end p 32
###begin p 33
###xml 122 127 <span type="species:ncbi:9606">human</span>
Together, these data suggest that the HAd37 fiber head sialic acid binding site is a key determinant in the attachment to human erythrocytes.
###end p 33
###begin p 34
###xml 63 65 63 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 532 534 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 593 602 593 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g002">Figure 2B</xref>
###xml 57 60 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 140 143 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 278 281 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 402 405 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 526 529 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Using the above approach, we detected minimal binding of CAV-2Hwt to erythrocytes (data not shown), possibly because the affinity of single CAV-2 fiber heads is low, the high affinity polyclonal antibody binding out-competed the weaker erythrocyte binding, and/or the number of CAV-2 fiber head receptors on erythrocytes is low. To address the potential competition, we incubated fluorescently labeled CAV-2 fiber heads with erythrocytes to circumvent the use of antibodies. Here we detected low, but reproducible, binding of CAV-2Hwt to mock-, as well as neuraminidase-treated, erythrocytes (Figure 2B).
###end p 34
###begin p 35
###xml 34 37 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Together, these data suggest that CAV-2 erythrocyte binding is notably less dependent on sialic acid than HAd37, and the lower binding may be due to reduced affinity or fewer receptors.
###end p 35
###begin p 36
###xml 295 304 295 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s002">Figure S2</xref>
###xml 313 315 313 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 390 392 390 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 400 404 400 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;2</sup>
###xml 478 482 478 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;1</sup>
###xml 564 566 564 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 577 581 577 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;2</sup>
To address sialic acid-fiber head interaction using a cell-free system, glycophorin or asialoglycophorin (asialoGP) were immobilized on BIAcore sensor chips and increasing concentrations of HAd37 fiber heads were assayed. All binding curves had a square shape, suggesting high on and off rates (Figure S2). HAd37Hwt bound to glycophorin, but less efficiently to asialoGP. Compared to HAd37Hwt, HAd37HSA-2 bound equally to asialoGP, but less to glycophorin. Interestingly, HAd37HSA-1 (Lys345Glu) bound less efficiently to glycophorin and asialoGP compared to HAd37Hwt and HAd37HSA-2, which suggests that HAd37 agglutination may be charge-dependent.
###end p 36
###begin p 37
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 83 86 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Consistent with the erythrocyte binding data, we found very little binding between CAV-2Hwt and glycophorin or asialoGP (data not shown). Overall, the SPR results reflect the results obtained using flow cytometry with mock or neuraminidase-treated erythrocytes.
###end p 37
###begin title 38
###xml 27 30 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Structural analysis of the CAV-2 fiber head suggests a sialic acid binding site
###end title 38
###begin p 39
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Schoehn1">[32]</xref>
###xml 783 792 783 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s003">Figure S3</xref>
###xml 178 181 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 264 267 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 445 448 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 709 712 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Our results suggested that HAd37 hemagglutination was due to sialic acid binding via the sialic acid binding site in the fiber head. Although we have no evidence suggesting that CAV-2 can use sialic acid as a functional receptor, it is possible that the efficient CAV-2 agglutination of human erythrocytes is due to multiple and coordinated binding of sialic acid. For example, each of the 12 homotrimeric fiber heads on the end of the flexible CAV-2 shaft [32] could bind three sialic acid moieties (theoretically up to 36/capsid). Because the predicted subgroup D fiber head hemagglutination domains (in the CD and GH loops) appear to be well conserved, we tried to identify the corresponding domain in the CAV-2 fiber head using a mutagenesis strategy based on sequence homology (Figure S3). This approach was unsuccessful (data not shown), suggesting that Ad hemagglutination sites are not strictly conserved.
###end p 39
###begin p 40
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Seiradake1">[24]</xref>
###xml 322 330 322 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s006">Table S1</xref>
###xml 79 82 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 256 259 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
To address possible sialic acid binding via an alternative approach, we soaked CAV-2 fiber head crystals in solutions containing 2-3 sialyl-D-lactose. The crystal diffracted to 1.9 A and the structure was solved by molecular replacement using our model of CAV-2 fiber head [24] (crystallographic details are summarized in Table S1). The electron density maps showed clear density for six N-acetyl neuraminic acid (Neu5AC) moieties in the asymmetric unit, three per fiber head trimer. Sialyl-lactose is composed of three sugar rings, the sialic acid moiety being linked to lactose (galactose-glucose). The density for the lactose moieties was weak, implying that these are flexible within the crystal. Only one of the six galactose rings in the asymmetric unit could be modeled. This molecule is located in between the two fiber head trimers in the asymmetric unit and forms a distant hydrogen bond (distance 3.25 A) to Lys503 via the galactose oxygen 6. It is unlikely that this interaction is enough to immobilize the galactose ring because the other five galactose moieties in the asymmetric unit are not equally well visible in the electron density. More likely, the stabilization is due to the spatial restrictions imposed by the proximity of the other fiber head trimer.
###end p 40
###begin p 41
###xml 265 276 265 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g003">Figure 3A&#8211;D</xref>
###xml 433 442 433 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s002">Figure S2</xref>
###xml 647 656 647 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g003">Figure 3E</xref>
###xml 759 768 759 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g003">Figure 3F</xref>
###xml 857 861 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Arnberg2">[33]</xref>
###xml 984 999 984 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g003">Figure 3C and D</xref>
###xml 46 49 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 149 152 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 690 693 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
We found that the sialic acid binding site on CAV-2 head is distinct, both in sequence and location, from that found on the HAd37 fiber head. On the CAV-2 fibers head, sialic acid binds further away from the three-fold symmetry axis at the periphery of the trimer (Figure 3A-D). The residues involved in binding (Asn435, Ser419, Ser416, Gln417 and Arg515) do not align with those involved in sialic acid-binding by HAd37 fiber head (Figure S2). The HAd37 sialic acid binding site consists of three residues forming hydrogen bonds (Tyr213, Pro317 and Lys345) and two residues contacting sialic acid in hydrophobic interactions (Tyr308 and Val322) (Figure 3E). All seven interactions between CAV-2 fiber head and sialic acid are hydrogen bonds or salt bridges (Figure 3F), suggesting a relatively strong interaction compared to HAd37. Unlike HAd37 fiber head [33], no hydrophobic contacts contribute to sialic acid binding. Finally, sialic acid binds within a basic patch in each head (Figure 3C and D).
###end p 41
###begin title 42
###xml 17 20 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Structure of the CAV-2 fiber head in complex with sialic acid and CAR.
###end title 42
###begin p 43
###xml 21 24 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 263 266 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 509 512 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 671 674 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
A. Ribbon diagram of CAV-2 fiber head in complex with sialyl-D-lactose (red = Neu5AC, yellow = fiber head). B. Cartoon representation of HAd37 fiber head in complex with sialyl-D-lactose (red = sialic acid, blue = fiber head). C. Surface charge representation of CAV-2 fiber head and cartoon representation of sialic acid as found in the complex. D. Surface charge representation of HAd37 fiber head and cartoon representation of sialic acid as found in the complex. E. Representation of the contacts between CAV-2 fiber head (purple) and sialic acid (yellow). F. Representation of the contacts between HAd37 fiber head (purple) and Neu5AC (yellow). G. Ribbon diagram of CAV-2 fiber head in complex with CAR D1 and sialyl-D-lactose (red = Neu5AC, green = CAR, yellow = fiber head). H. Ribbon diagram of HAd37 fiber head in complex with CAR and sialyl-D-lactose (red = Neu5AC, green = CAR, blue = fiber head).
###end p 43
###begin title 44
###xml 0 3 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
CAV-2 and HAd37 fiber heads bind CAR and sialic acid simultaneously
###end title 44
###begin p 45
###xml 1079 1094 1079 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g003">Figure 3G and H</xref>
###xml 29 32 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 116 119 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 221 224 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 237 240 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 392 395 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 526 529 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Our results showing that the CAV-2 fiber head contains a sialic acid binding site creates a paradox: both HAd37 and CAV-2 fiber heads contain CAR and sialic acid binding sites - but HAd37 uses sialic acid and CD46, while CAV-2 uses CAR (CAV-2 does not use CD46 to infect cells, unpublished data) to infect cells. To determine if sialic acid and CAR binding were mutually exclusive, we soaked CAV-2 or HAd37 fiber head crystals in complex with CAR in solutions containing sialyl-D-lactose. Crystals containing the complex with CAV-2 fiber head diffracted to 2.9 A and contained 12 chains of fiber head bound to 12 chains of CAR D1 and 12 sialyl-D-lactose molecules in the asymmetric unit (space group I422). Crystals containing the complex with HAd37 fiber head diffracted to 1.55 A and contained one chain of fiber head in complex with one CAR D1 molecule and one sialyl-D-lactose molecule in the asymmetric unit (space group I23). For both structures the electron density maps showed clear density for sialic acid, but not lactose, at the expected positions on the fiber heads (Figure 3G and H).
###end p 45
###begin p 46
###xml 36 39 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Together, our data demonstrate that CAV-2 and HAd37 sialic acid binding sites do not overlap with the CAR binding sites, and both fiber heads can bind CAR and sialyl-D-lactose simultaneously.
###end p 46
###begin title 47
###xml 0 3 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
CAV-2 fiber head-erythrocyte interactions may be partially charge dependent
###end title 47
###begin p 48
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Arnberg2">[33]</xref>
###xml 636 644 636 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g004">Figure 4</xref>
###xml 1009 1010 985 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1091 1092 1067 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1130 1134 1106 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Cichon1">[29]</xref>
###xml 1135 1139 1111 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Lyons1">[34]</xref>
###xml 146 149 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 232 235 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Arnberg and colleagues previously showed that HAd37 interaction with sialic acid was inhibited at high salt concentration [33]. To determine if a CAV-2-erythrocyte interaction was at least partially charge dependent, we incubated a CAV-2 vector expressing GFP (CAVGFP) or a HAd5 vector expressing GFP (AdGFP) with mock- or neuraminidase-treated erythrocytes in PBS containing increasing concentrations of ions. We then pelleted the erythrocytes by centrifugation, removed an aliquot of the supernatant, added it to cells, and assayed the cells for GFP expression by flow cytometry 24 hr post-infection. Using mock-treated erythrocytes (Figure 4), we found that at physiological salt concentrations approximately80% of CAVGFP was removed from the supernatant, while at higher salt concentration (300 mM NaCl) approximately60% of CAVGFP was removed. When using neuraminidase-treated erythrocytes, we again found that CAVGFP was efficiently removed from the supernatant. All the test samples were significantly (P<0.01) different from the control, as well as from the mock-treated 150 mM NaCl (P<0.05). Consistent with other studies [29],[34] AdGFP was also efficiently (90%) removed from the supernatant after the incubation with mock- (or neuraminidase-) treated erythrocytes.
###end p 48
###begin title 49
###xml 9 12 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 26 31 <span type="species:ncbi:9606">human</span>
HAd5 and CAV-2 binding to human erythrocyte.
###end title 49
###begin p 50
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 111 112 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 508 509 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 624 625 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 704 705 690 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
CAVGFP or AdGFP was incubated with 2.5x107 erythrocytes at 1 particle per cell (equivalent to approximately5x109 pp in 1 ml of blood) in PBS and +/- additional NaCl. The erythrocytes were pelleted by slow speed centrifugation, and an aliquot of the supernatant was removed and incubated with a monolayer of the most permissive and sensitive cells (911 cells for AdGFP and DKCre cells for CAVGFP). These latter cells were analyzed for GFP expression by flow cytometry 24 hr post-incubation. The percent of GFP+ cells versus the control is shown for mock- or neuraminidase-treated erythrocytes. All samples are significantly (P<0.05) different from the controls. In addition, the star (*) corresponds to a P value of <0.01 between the mock-treated erythrocytes at physiologically relevant salt concentration (150 mM) and the controls.
###end p 50
###begin p 51
###xml 56 59 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 185 188 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 197 202 <span type="species:ncbi:9606">human</span>
These data suggest that, like HAd37, a modest degree of CAV-2-erythrocyte interactions may depend on electrostatic interactions. In addition, both the CAR-tropic adenoviruses (HAd5 and CAV-2) bind human erythrocytes at physiological salt concentrations.
###end p 51
###begin title 52
###xml 42 45 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
CAR expression by erythrocytes influences CAV-2 agglutination
###end title 52
###begin p 53
###xml 92 95 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
While our results show that HAd37 hemagglutination is due primarily to sialic acid binding, CAV-2 hemagglutination appeared more complex. We therefore developed additional tests to address the molecular and structural basis. Due its sensitive and semi-quantitative potential, we returned to hemagglutination assays to understand the erythrocyte interactions.
###end p 53
###begin p 54
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Seiradake2">[35]</xref>
###xml 661 663 661 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 714 718 714 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;1</sup>
###xml 729 733 729 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;2</sup>
###xml 820 827 820 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000277-t002">Table 2</xref>
###xml 17 20 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 423 426 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 655 658 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 708 711 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 723 726 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 739 742 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 965 968 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Freshly purified CAV-2Hwt, which predominantly consists of individual trimeric fiber heads, did not cause hemagglutination, presumably because it is not sufficiently multivalent to crosslink erythrocytes. However, several His-tagged Ad fiber heads, including those of HAd41 short fiber [35] and HAd37, form multimers that dissociate into single trimeric fiber heads upon removal of the histidine tag. Similarly, His-tagged CAV-2 fiber head forms multimers of a defined size that are stable on a size-exclusion column and can be visualized with an electron microscope (not shown). Removal of the His-tag yields single fiber heads. We found that His-tagged CAV-2Hwt agglutinated erythrocytes, while His-tagged CAV-2HSA-1 and CAV-2HSA-2 (two CAV-2 fiber heads with one or two mutations in the sialic acid binding site, see Table 2) showed reduced hemagglutination titers. However, we could not exclude the possibility that the reduced hemagglutination in these latter CAV-2H constructs was due to electrostatic interactions (the mutations modified the charge of the fiber heads).
###end p 54
###begin p 55
###xml 70 79 70 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s004">Figure S4</xref>
###xml 457 459 457 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 465 474 465 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g005">Figure 5A</xref>
###xml 697 699 697 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 707 711 707 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;1</sup>
###xml 838 842 826 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAR&#8722;</sup>
###xml 16 19 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 251 254 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 376 379 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 451 454 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 691 694 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 701 704 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 774 777 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 832 835 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 986 989 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
We next assayed CAV-2 hemagglutination using a competition assay (see Figure S4 for schema). In these competition assays, we pre-incubated erythrocytes with fiber heads, antibodies, salt and/or neuraminidase. Then the erythrocytes were incubated with CAV-2 and compared to mock-treated erythrocytes. We found that hemagglutination could be >256-fold reduced by pre-incubating CAV-2 with anti-fiber head antibodies, or pre-incubating erythrocytes with CAV-2Hwt (see Figure 5A for specific example and 5B for cumulative data). Pre-incubating the erythrocytes with the head from HAd5 or performing the assay in 225 mM NaCl led to modest 2 to 4-fold reductions. Unexpectedly, we found that like CAV-2Hwt, CAV-2HSA-1 notably reduced agglutination (approximately16-fold), while a CAV-2 fiber head with a mutation in the CAR binding site (CAV-2HCAR-) had a modest approximately2-fold reduction. In most cases, pre-treating erythrocytes with neuraminidase had a fairly small additive effect of CAV-2 hemagglutination.
###end p 55
###begin title 56
###xml 0 3 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
CAV-2 hemagglutination assays using competition with fiber heads, +/- increased salt concentrations and +/- neuraminidase.
###end title 56
###begin p 57
###xml 55 64 55 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s004">Figure S4</xref>
###xml 649 653 637 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;1</sup>
###xml 489 494 <span type="species:ncbi:9606">human</span>
###xml 511 514 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 643 646 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 659 662 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1125 1128 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
A. Examples of the results from competition assay (see Figure S4 for the schema of the approach). The pink shaded well corresponds to the last well that shows agglutination. A shift to the left of the pink shade signifies decreased agglutination due to blocking of the virus binding site or removal of an attachment ligand. A 2-fold decrease in agglutination would correspond to a one-well shift to the left of the last well that showed agglutination. Top control panel = agglutination of human erythrocytes by CAV-2 (for example approximately8 pp/erythrocyte in the pink shaded well on top row). Middle panel = erythrocytes preincubated with CAV-2HSA-1 (the CAV-2 fiber head that contains a mutation in the sialic acid binding site but can still bind CAR) prior to the agglutination assay (approximately96 pp/erythrocyte in the pink shaded well, top row), which equals an approximately8 to 16-fold decrease from the control). Bottom panel = the same as the middle panel except that the erythrocytes were pretreated with neuraminidase (16 to 32-fold decrease). B. The graph shows the cumulative data from competition assays. CAV-2- agglutination of mock-treated erythrocytes was used as the starting point. The blocking agent was used with mock (black bars) or neuraminidase-treated (grey bars) erythrocytes. All assays were performed at least three times.
###end p 57
###begin p 58
###xml 82 84 82 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 95 99 95 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SA&#8722;1</sup>
###xml 114 118 114 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAR&#8722;</sup>
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Nicol1">[36]</xref>
###xml 76 79 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 89 92 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 108 111 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 135 138 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 187 190 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 363 368 <span type="species:ncbi:9606">human</span>
###xml 373 376 <span type="species:ncbi:10116">rat</span>
Together, these data suggest that the CAR binding site, which is present in CAV-2Hwt and CAV-2HSA-1 but not CAV-2HCAR-, is involved in CAV-2 agglutination of human erythrocytes. That the CAV-2 CAR binding site is involved in erythrocyte binding is consistent with the study by Nicol et al. [36], which showed that a CAR-ablated HAd5 vector no longer agglutinated human and rat erythrocytes.
###end p 58
###begin p 59
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Lyons1">[34]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Freimuth1">[37]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Eshghi1">[38]</xref>
###xml 698 707 698 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g006">Figure 6A</xref>
###xml 1007 1016 1007 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g006">Figure 6B</xref>
###xml 1165 1167 1165 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1193 1202 1193 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g002">Figure 2B</xref>
###xml 678 683 <span type="species:ncbi:9606">human</span>
###xml 927 932 <span type="species:ncbi:9606">human</span>
###xml 937 940 <span type="species:ncbi:10116">rat</span>
###xml 953 958 <span type="species:ncbi:10090">mouse</span>
###xml 960 963 <span type="species:ncbi:9615">dog</span>
###xml 965 971 <span type="species:ncbi:9986">rabbit</span>
###xml 1097 1102 <span type="species:ncbi:9606">human</span>
###xml 1159 1162 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
The presence of CAR on erythrocytes would be inconsistent with other reports [34]. Among other functions, CAR acts as a homodimeric cell adhesion molecule at tight gap junctions [37]. However, the expression of cell adhesion molecules during erythropoiesis is not unprecedented [38]. Erythrocytes from some species express cell adhesion molecules during the early stages of differentiation that are thought to be involved in interaction with macrophages. We therefore incubated erythrocytes with anti-CAR antibodies that recognize the extracellular domain of CAR and assayed expression using flow cytometry. We found low, but reproducible, CAR expression on the cell surface of human erythrocytes (Figure 6A). To assay CAR expression using another approach, we used western blot analysis to screen erythrocytes from several species. Using an anti-CAR Ab that recognizes the cytoplasmic domain of CAR we found CAR expression on human and rat, but not on mouse, dog, rabbit and nonhuman primate erythrocytes (Figure 6B and data not shown). Again, our results showed a relatively low level of CAR on human erythrocytes, which is consistent with the low level of CAV-2Hwt binding to erythrocytes (Figure 2B).
###end p 59
###begin title 60
###xml 40 43 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
CAR expression by erythrocytes leads to CAV-2 induced agglutination.
###end title 60
###begin p 61
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 380 381 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 403 404 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 869 877 857 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g005">Figure 5</xref>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 295 301 <span type="species:ncbi:10090">murine</span>
###xml 336 341 <span type="species:ncbi:9606">human</span>
###xml 387 392 <span type="species:ncbi:10090">mouse</span>
###xml 411 416 <span type="species:ncbi:9606">human</span>
###xml 418 421 <span type="species:ncbi:10116">rat</span>
###xml 423 428 <span type="species:ncbi:10090">mouse</span>
###xml 453 458 <span type="species:ncbi:10090">mouse</span>
###xml 589 594 <span type="species:ncbi:10090">mouse</span>
###xml 661 665 <span type="species:ncbi:10090">mice</span>
###xml 734 737 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
A. Flow cytometry analysis of CAR expression by human, mouse and GATA1-CAR mouse erythrocytes using the anti-CAR E1.1, which recognizes the native form of CAR. B. Western blot analysis of CAR expression using the polyclonal anti-CAR antibody CAR1605, which recognizes the denatured form of CAR: murine fibroblast (NIH 3T3 cells, CAR-), human embryonic kidney cells (293 cells, CAR+) and mouse liver (CAR+), and human, rat, mouse (C57BL/6) and GATA1-CAR mouse erythrocytes. An anti-actin staining was used to control the protein input. C. Hemagglutination assay using C57BL/6 and GATA1-CAR mouse erythrocytes. No significant agglutination was found with C57BL/6 mice while GATA1-CAR erythrocytes agglutinated with approximately3 pp of CAV-2/erythrocyte (pink shaded wells). D. Hemagglutination competition assay using GATA-CAR erythrocytes and performed as described in Figure 5 using a higher concentration of the fiber head (as would be expected due to the higher levels of CAR on GATA-CAR erythrocytes).
###end p 61
###begin p 62
###xml 320 329 320 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s005">Figure S5</xref>
###xml 63 66 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 120 125 <span type="species:ncbi:9606">human</span>
###xml 183 186 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 202 205 <span type="species:ncbi:10116">rat</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:9615">dogs</span>
###xml 258 265 <span type="species:ncbi:9986">rabbits</span>
These data suggest that CAR binding is a significant factor in CAV-2, and likely other CAR-tropic Ads, interaction with human erythrocytes. This also is consistent with the fact that CAV-2 agglutinates rat erythrocytes, but not erythrocytes from mice, dogs, rabbits or some nonhuman primates (as well as other species) (Figure S5).
###end p 62
###begin p 63
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Asher1">[28]</xref>
###xml 592 605 592 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g006">Figure 6A &amp; B</xref>
###xml 892 901 892 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g006">Figure 6C</xref>
###xml 1103 1112 1103 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g006">Figure 6D</xref>
###xml 31 34 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 440 445 <span type="species:ncbi:10090">mouse</span>
###xml 634 639 <span type="species:ncbi:9606">human</span>
###xml 671 676 <span type="species:ncbi:9606">human</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 817 820 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1017 1020 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1083 1088 <span type="species:ncbi:9606">human</span>
If CAR binding plays a role in CAV-2 agglutination, then knocking down/blocking or artificially expressing CAR on erythrocytes should prevent/induce hemagglutination. Eliminating CAR on mature enucleated erythrocytes is technically challenging. Furthermore, to the best of our knowledge there are no known anti-CAR antibodies that completely block Ad attachment. On the other hand, CAR has been expressed on erythrocytes using a transgenic mouse line (GATA1-CAR) with the CAR cDNA downstream of the globin transcription factor 1 promoter [28]. Using flow cytometry and western blot analysis (Figure 6A & B), we compared the levels of human CAR expressed by GATA1-CAR and human erythrocytes. We then repeated the hemagglutination assays using erythrocytes from control (C57BL/6) and GATA1-CAR mice. We also found that CAV-2 agglutinated GATA1-CAR erythrocytes at a low particle-to-cell ratio (Figure 6C), while there was no agglutination of C57BL/6 erythrocytes. Equally important, competition assays with recombinant CAV-2 fiber heads gave profiles that were similar to when we used human erythrocytes (Figure 6D, and data not shown).
###end p 63
###begin p 64
Together, our data demonstrate that CAR expression by erythrocytes can lead to agglutination by CAR-tropic adenoviruses.
###end p 64
###begin title 65
The role of CAR in Ad biodistribution and pathogenesis
###end title 65
###begin p 66
###xml 36 40 36 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Waddington1">[39]</xref>
###xml 41 45 41 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Walters1">[40]</xref>
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 298 315 298 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro, ex vivo</italic>
###xml 521 528 521 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 372 375 <span type="species:ncbi:10116">rat</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
In spite of recent notable advances [39],[40], in vivo Ad biodistribution, tropism and pathogenesis for the CAR-tropic HAds are still poorly understood. Group C HAd serotypes 2 and 5 are the prototype Ads in terms of structure, tropism and pathogenesis. However, tropism has been primarily studied in vitro, ex vivo or in animal models. Our results showing that human and rat erythrocytes harbor CAR on their external membranes while mice and nonhuman primates do not, suggests that these latter animals poorly mimic the in vivo environment that Ads encounter.
###end p 66
###begin p 67
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 260 261 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 377 386 377 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g007">Figure 7A</xref>
###xml 514 517 514 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Lenaerts1">[6]</xref>
###xml 518 521 518 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Hierholzer1">[7]</xref>
###xml 700 701 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 786 795 774 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g007">Figure 7B</xref>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 437 442 <span type="species:ncbi:9606">human</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 907 910 <span type="species:ncbi:10116">rat</span>
###xml 929 933 <span type="species:ncbi:10090">mice</span>
To better address in vivo biodistribution of CAR-tropic Ads, we injected GATA1-CAR and control C57BL/6 mice with a HAd5 vector and quantified viral genome blood half-life and tissue distribution. We found that the viral load in the blood was 1000-fold higher (P<0.01) in GATA1-CAR versus isogenic control mice (CAR-negative erythrocytes) during the first 72 hr post-injection (Figure 7A). These data are reminiscent of the studies where human blood cells are routinely positive by qPCR for wild type HAd sequences [6],[7]. In addition, notably absent from the AdGFP-injected GATA1-CAR mice was transgene expression in the liver. Lack of transgene expression was also consistent with the significant (P<0.01) approximately25-fold difference in the mean viral load as quantified by qPCR (Figure 7B). The lack of efficient liver infection is also consistent with the generally unexpected and poor infection of rat liver compared to mice and nonhuman primates following injection of CAR-tropic Ad vectors.
###end p 67
###begin title 68
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Biodistribution of CAR-tropic HAd5 in GATA1-CAR mice.
###end title 68
###begin p 69
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 338 343 <span type="species:ncbi:10090">mouse</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 925 929 <span type="species:ncbi:10090">mice</span>
Mice were injected intravenously with an HAd5 vector expressing GFP (AdGFP) and blood and livers were recovered at the indicated times and assayed for vector genomes and/or GFP expression. A. qPCR of viral genomes in the blood at approximately15 min (0.25 hr), 6 hr, and 1 and 3 days post-injection normalized by copies of GAPDH for each mouse (four GATA1-CAR and four C57B/6 mice, the isogenic strain) (left hand panel) and the mean of each group (right hand panel). qPCR was performed twice in triplicate. B. Histological section from the liver of representative mice at day 3 (72 hr). GFP expression from AdGFP is indicated by the green cells (white arrows). The sections were stained with Hoechst to show the nuclei (in blue) and phalliodin-TRITC to show actin filaments (red, or yellow if an overlap with GFP signal) (left-hand panel). qPCR analysis of the viral genomes in the livers of four GATA1-CAR and four C57BL/6 mice at day 3 (right hand panel). qPCR was performed twice in triplicate.
###end p 69
###begin p 70
###xml 111 118 111 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 52 55 <span type="species:ncbi:10116">rat</span>
###xml 60 65 <span type="species:ncbi:9606">human</span>
Together, these data suggest that CAR expression by rat and human erythrocytes plays a significant role in HAd in vivo distribution and, in turn, determining which tissues are susceptible to infection.
###end p 70
###begin title 71
Discussion
###end title 71
###begin p 72
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 266 269 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
We initiated this study to examine a 50-year-old enigma of adenovirus biology. Our results demonstrate that HAd37 interaction with human erythrocytes is primarily due to sialic acid binding via a conserved sialic acid binding site on this subgroup D HAd fiber head. CAV-2, a serotype that like the prototype HAd5 is "CAR-tropic" and by most criteria is unrelated to HAd37, interacts with human erythrocytes via a mechanism depending on several factors, including most notably binding to CAR.
###end p 72
###begin p 73
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Burmeister1">[27]</xref>
###xml 191 194 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Most subgroup D HAd sialic acid binding site residues are conserved [27], and structural analysis suggest that they bind sialic acid in an equivalent fashion. Unexpectedly, we found that the CAV-2 fiber head harbors a sialic acid binding site. But, in contrast to the well-conserved location of the CAR binding domains on some Ad fiber heads, location of the sialic acid binding site is not conserved.
###end p 73
###begin p 74
###xml 1158 1162 1158 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Seiradake1">[24]</xref>
###xml 71 74 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Following the structure-based identification of the amino acids in the CAV-2 and HAd37 fiber heads that interact with sialic acid, we introduced mutations to assay the role of these sites in sialic acid binding and erythrocyte interaction. In a number of conditions and approaches we showed that hemagglutination by HAd37 depends primarily on sialic acid binding. First, removing sialic acids from erythrocytes with neuraminidase eliminated erythrocyte cross-linking by HAd37 and a chimeric capsid harboring the HAd37 fiber head. Likewise, pre-incubation with neuraminidase significantly reduced hemagglutination caused by protein complexes containing multiple copies HAd37 fiber heads. Second, mutating single residues in the sialic acid binding sites reduced the hemagglutination activity of these protein complexes. Third, wild type HAd37 fiber heads bound more efficiently to erythrocytes or glycophorin than those carrying a point mutation in the sialic acid binding site. Our binding assays using wild type and mutated HAd37 heads also suggested that the sialic acid affinity is partially charge-driven. In addition, although HAd37 head also binds CAR [24], in the context of the virus it does not appear to use CAR as a receptor, possibly due to its relatively short fiber. Therefore, CAR on erythrocytes is likely to be less important for HAd37 biodistribution.
###end p 74
###begin p 75
###xml 861 865 861 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Schoehn1">[32]</xref>
###xml 125 128 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 223 226 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 358 361 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 415 418 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 698 701 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 814 817 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 889 892 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
In spite of our structural data showing a well-defined sialic acid binding site, we could not detect notable binding between CAV-2 fiber head and glycophorin, a highly sialated protein. It was possible that the affinity of CAV-2 fiber head to erythrocytes or glycophorin was lower than that of HAd37 fiber head, and that the efficient erythrocyte binding of CAV-2 depended on the avidity of multiple fibers. As the CAV-2 fiber head is less positive than HAd37 fiber head (pI's of 8.4 and 9.2 respectively), this could have explained the lower affinity. The affinity between virus proteins and sialic acid is usually in the millimolar range; therefore it was conceivable that the affinity of single CAV-2 fiber heads to erythrocytes or glycophorin was low. Consistent with this assumption, we previously found that CAV-2 is more neutrally charged than other Ads [32]. Paradoxically though, CAV-2 agglutinates at a lower particle-to-cell ratio than HAd37 and our crystallography data suggested that sialic acid binding should be at least as strong as HAd37. However, one cannot reliably predict affinity from structural data.
###end p 75
###begin p 76
###xml 138 140 138 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i)</bold>
###xml 260 263 260 263 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ii)</bold>
###xml 264 279 <span type="species:ncbi:10090">transgenic mice</span>
The identification of CAR expression by erythrocytes from species that are agglutinated by CAR-tropic Ads is a crucial observation. Using i) competition assays with recombinant fiber heads harboring point mutations in the sialic acid and CAR binding sites and ii) transgenic mice expressing CAR on erythrocytes, we characterized the unexpected and significant role of CAR in Ad binding.
###end p 76
###begin p 77
###xml 148 150 148 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i)</bold>
###xml 236 239 236 239 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ii)</bold>
###xml 281 285 281 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iii)</bold>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Arnberg2">[33]</xref>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Arnberg2">[33]</xref>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Arnberg2">[33]</xref>
###xml 1097 1101 1097 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Seiradake1">[24]</xref>
###xml 1235 1239 1235 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Marusyk1">[12]</xref>
###xml 367 372 <span type="species:ncbi:9606">human</span>
###xml 451 456 <span type="species:ncbi:9606">human</span>
###xml 840 843 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 892 895 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1014 1017 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1037 1042 <span type="species:ncbi:9606">human</span>
###xml 1212 1215 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1378 1381 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1534 1537 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
As mentioned previously, Ad serotypes differ in their ability to bind erythrocytes from various species. Our study suggests that this may be due to i) an interaction with different chemical variants, linkages and ratios of sialic acid, ii) the presence and affinity to CAR, and/or iii) the pI's of the head [33]. For example, some non-CAR-tropic Ads that agglutinate human erythrocytes may preferentially bind Neu5AC, the most abundant sialic acid on human erythrocytes. With respect to charge, both HAd37 and HAd19p bind sialic acid with equal affinity and the only two residues that differ between their heads are not close to the sialic acid-binding site [33]. With the limited amount of data available, subgroup D HAds tend to have heads with higher pI's and interact with sialic acid [33]. Interestingly, the residues that make up the CAV-2 sialic acid binding site are conserved in the CAV-1 fiber head (data not shown), suggesting a conserved sialic acid binding function. With respect to CAR affinity, the CAV-2 fiber head binds human CAR with the highest affinity of any fiber head known [24], which may favor its efficient hemagglutination. In contrast to other Ads, higher temperatures poorly inhibit CAV-2 hemagglutination [12], again suggesting a role for the high-affinity attachment to CAR. This is also consistent with a rather large difference between HAd5 and CAV-2 hemagglutination: to the best of our knowledge the HAd5 head does not harbor a sialic acid binding site and its pI (6.25) is less basic than HAd37 or CAV-2. Finally, we cannot exclude a role of the inter- and intra-species differences in the quantity of CAR expressed by erythrocytes.
###end p 77
###begin p 78
###xml 240 248 240 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000277-g006">Figure 6</xref>
###xml 810 812 810 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 925 929 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Morrissey1">[41]</xref>
###xml 1048 1052 1048 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Raper1">[42]</xref>
###xml 104 108 <span type="species:ncbi:9615">dogs</span>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 116 123 <span type="species:ncbi:9986">rabbits</span>
###xml 201 204 <span type="species:ncbi:10116">rat</span>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 328 331 <span type="species:ncbi:10116">rat</span>
###xml 761 766 <span type="species:ncbi:10090">mouse</span>
###xml 902 905 <span type="species:ncbi:10116">rat</span>
Phylogenetically, CAR expression by erythrocytes appears to be random; we tested several other species (dogs, mice, rabbits, lemurs and monkeys) and did not find CAR expression. However, CAR levels on rat erythrocytes were relatively high (Figure 6) and consistent with our hypothesis that CAR-tropic Ads agglutinates human and rat erythrocytes via CAR binding. It is possible, but unlikely, that our lack of detection of CAR on erythrocytes on some species was due to the limit of sensitivity of our bank of anti-CAR antibodies, which nonetheless detected CAR expression on other cell types from these species (not shown). In the context of the significant amount of HAd5-mediated gene transfer data, our data highlights an important parallel. While a 30-gram mouse can be injected intravenously with up to 1012 pp of an HAd5 vector with minimal side effects, injection of the same dose in a 250-gram rat is normally lethal [41]. Whether our data have a bearing on the death following portal vein injection of a HAd5 vector during a phase I trial [42] is unknown, but deserves consideration.
###end p 78
###begin p 79
###xml 189 198 189 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s004">Figure S4</xref>
###xml 201 223 201 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Canis lupus familiaris</italic>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Sumner1">[43]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Chomel1">[45]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Arnberg1">[25]</xref>
###xml 576 579 576 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Soudais1">[5]</xref>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Haywood1">[46]</xref>
###xml 1005 1009 1005 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Kremer1">[47]</xref>
###xml 1010 1014 1010 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Soudais3">[50]</xref>
###xml 1232 1239 1232 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 128 131 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 144 147 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 171 174 <span type="species:ncbi:9615">dog</span>
###xml 201 223 <span type="species:ncbi:9615">Canis lupus familiaris</span>
###xml 256 259 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 286 289 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 308 315 <span type="species:ncbi:9614">coyotes</span>
###xml 351 359 <span type="species:ncbi:9654">raccoons</span>
###xml 478 481 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 991 994 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1041 1044 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Similar to the CAR binding domain in HAd37, we can only speculate about the importance of sialic acid binding in the biology of CAV-2. Although CAV-2 does not agglutinate dog erythrocytes (Figure S4), Canis lupus familiaris may not be the original host of CAV-2: seroprevalence against CAV-2 can be found in coyotes, bears, pandas, skunks, mongooses, raccoons and foxes [43]-[45]. It is paradoxical that HAd37 binds CD46, sialic acid and CAR - yet does not use CAR [25] - while CAV-2 binds both sialic acid and CAR and to the best of our knowledge uses only CAR as a receptor [5]. We cannot exclude the possibility that in some cell types sialic acid binding provides a first low-affinity attachment to the cell surface, while CAR-binding is followed in a second step, providing a high-affinity binding. Similar two-step mechanisms have been proposed for other viruses [46]. It is tempting to speculate that sialic acid binding may play a role in the preferential transduction of neurons by CAV-2 vectors [47]-[50]. Our crystal structure of CAV-2 fiber head in complex with CAR and sialyl-D-lactose demonstrates that the ternary complex of the three molecules is stable. There is no indication that this should not be the case also in vivo.
###end p 79
###begin p 80
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Marusyk1">[12]</xref>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Eiz1">[21]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-PringAkerblom1">[23]</xref>
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Cichon1">[29]</xref>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Nicol1">[36]</xref>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Bauer1">[51]</xref>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Shortridge1">[53]</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Lyons1">[34]</xref>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 96 99 <span type="species:ncbi:10116">rat</span>
Our data and numerous reports describing the ex vivo interaction of CAR-binding HAd5 with human/rat erythrocytes [12], [21]-[23], [29], [36], [51]-[53] strongly suggest this interaction probably occurs after the intravascular injection of CAR-tropic vectors. Notably, Lyons et al. showed that that >90% HAd5 vector DNA was associated with blood cells following intratumoral injection during a clinical trial [34].
###end p 80
###begin p 81
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Zoller1">[54]</xref>
###xml 1023 1027 1023 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Asher1">[28]</xref>
###xml 216 221 <span type="species:ncbi:9606">human</span>
###xml 652 658 <span type="species:ncbi:9606">humans</span>
It is likely that erythrocyte binding occurs during wild type infection of some HAds (as well as coxsackie B viruses) that use CAR, which will certainly lead to altered biodistribution. HAd DNA is routinely found in human blood cells by PCR. It is also a common misconception that Ads are rapidly cleared following a classical immune response. Numerous clinical cases strongly suggest that latent HAds can readily resurface if the host is immunosuppressed. The fate of particles that stick to erythrocytes under natural or artificial (i.e. vector injections) conditions is probably complex. For example, HAd5-induced liver disease in immunocompromised humans is relatively common. In contrast, immunocompromised nonhuman primates are rarely diagnosed with simian Ad (SAV)-induced liver disease [54]. Does CAR expression on erythrocytes lead to an advantage for host or virus? Has CAR expression on erythrocytes put a selective pressure on Ads (and coxsackie B viruses that also bind CAR) to avoid an erythrocyte virus trap [28]? Or has CAR expression by erythrocytes allowed HAds to thrive because it has allowed open access to so many more tissues and cell types?
###end p 81
###begin p 82
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo.</italic>
###xml 332 339 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 367 373 367 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Sivan1">[55]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Louie1">[56]</xref>
###xml 1095 1099 1095 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Waddington1">[39]</xref>
###xml 862 867 <span type="species:ncbi:9606">human</span>
In summary, our results resolve a longstanding enigma of Ad-erythrocyte interaction in vitro and in vivo. In addition, we provide new insights into virus-erythrocyte interactions that will allow us to better understand HAd pathogenesis and facilitate the engineering of safer, more efficient gene transfer vectors. Although in most in vivo scenarios hemagglutination per se is unlikely to occur due to the turbulence that erythrocytes encounter in the circulation, sequestering of vector particles by erythrocytes must diminish gene transfer efficacy. Interest in Ad biology is continually growing due to the increasing incidence of HAd-induced morbidity and mortality during immunosuppression [55],[56], and because Ad-derived vectors are the most commonly used vectors in gene therapy clinical trials. The identification of fiber head mutants that do not bind human erythrocytes may be of interest. Equally important may be the need to screen fiber heads from other serotypes for sialic acid and CAR binding domains. Combined with HAd interactions with vitamin K-dependent coagulation factors [39], our study adds another critical element in the interaction with blood components, biodistribution and pathogenesis.
###end p 82
###begin title 83
Materials and Methods
###end title 83
###begin title 84
Viruses, vectors and antibodies
###end title 84
###begin p 85
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Chiu1">[30]</xref>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Glasgow1">[31]</xref>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Kremer3">[57]</xref>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Le1">[58]</xref>
###xml 670 672 664 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 0 3 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 57 60 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 287 290 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 328 331 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 813 818 <span type="species:ncbi:10090">mouse</span>
###xml 872 878 <span type="species:ncbi:9986">rabbit</span>
###xml 914 919 <span type="species:ncbi:10090">mouse</span>
###xml 974 979 <span type="species:ncbi:10090">mouse</span>
###xml 998 1003 <span type="species:ncbi:9606">human</span>
###xml 1016 1020 <span type="species:ncbi:9925">goat</span>
CAV-2 (CAVGFP), HAd5 (AdGFP), HAd37, and the hybrid HAd5-CAV-2H (Ad5Luc1-CK) and HAd5-HAd37F (Ad37f) vectors were prepared as previously described [30],[31],[57],[58]. Briefly, CAVGFP and AdGFP are E1-deleted vectors expressing GFP. The capsids contain no modifications. The hybrid HAd5-CAV-2H vector contains the fiber head of CAV-2 on the HAd5 capsid. HAd5-HAd37F vector contains the HAd37 fiber (shaft and head) on the HAd5 capsid. All vectors were purified by double banding on CsCl gradients, CsCl was removed using PD-10 columns (Pharmacia). The vectors were stored in phosphate-buffered saline (PBS) containing 10% glycerol at -80degreesC. Stock titers were >1x1012 physical particles/ml with >1 infectious particle/5 physical particles. Anti-CAR antibodies tested in this study included E1.1 a monoclonal mouse (S. Hemmi, University of Zurich), CAR1605 polyclonal rabbit (J. Zabner), MoAbE(mh)1 monoclonal mouse (S. Carson, University of Nebraska), and AF2654 (anti-mouse) and AF3336 (anti-human) polyclonal goat (R & D Systems).
###end p 85
###begin title 86
Negative staining
###end title 86
###begin p 87
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Schoehn2">[59]</xref>
The recombinant fiber heads and dodecahedral sample were loaded between the mica-carbon interface as described [59]. The samples were stained using 2% sodium silico tungstate pH 7.5 and air-dried. Images were taken under low-dose conditions in an EX1200-II JEOL electron microscope working at 100 kV and with a nominal magnification of 40,000. The images were scanned on a Z/I Imaging scanner (Photoscan TD) with a pixel size of 14 mm (3.5 A per pixel at the sample level).
###end p 87
###begin title 88
Generation of recombinant fiber head and labeling with fluorophores
###end title 88
###begin p 89
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Seiradake1">[24]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Seiradake1">[24]</xref>
###xml 1136 1140 1130 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAR&#8722;</sup>
###xml 1226 1228 1220 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1259 1260 1253 1254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 196 199 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 831 849 <span type="species:ncbi:12227">tobacco etch virus</span>
###xml 851 854 <span type="species:ncbi:12227?0.9375">TEV</span>
###xml 955 958 <span type="species:ncbi:12227?0.9375">TEV</span>
###xml 1130 1133 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 1220 1223 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Fiber head constructs were cloned into pPROEX HTb (Life Technologies) and expressed with a cleavable His-tag as described previously [24]. HAd37 fiber head constructs contain residues 177-365 and CAV-2 fiber head constructs contain residues 358-542. Point mutations were introduced using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) and polymerase chain reaction (PCR). Protein purification was performed as described [24]. Briefly, cells were incubated in lysis buffer (20 mM Tris-HCl pH 7.5, 300 mM NaCl, 20 mM imidazole, (Boehringer Complete EDTA-free protease inhibitor cocktail), centrifuged, and fiber head bound to a Ni-NTA column (Qiagen). Eluted protein was either directly loaded onto a Superdex200 column for hemagglutination experiments with tagged fiber head, or incubated overnight with 1/100 His-tagged tobacco etch virus (TEV) protease at 10degreesC. Proteins were then dialyzed against lysis buffer and uncleaved protein and TEV protease bound to a Ni-NTA resin. Untagged fiber head was loaded onto a Superdex200 column using the same buffer as for tagged protein (20 mM Tris pH7.5 and 300 mM NaCl). CAV-2HCAR- was labeled using Alexa488 Microscale Protein Labeling Kit (Molecular Probes). CAV-2Hwt was dialyzed in PBS 0.1 M NaCO3 pH 9.3 and labeled using mono-reactive dyes (Cy3, Cy5 or Alex488, Amersham Bioscience) for 45 min at room temperature. The elution of labeled protein was performed with 2 ml of PBS using NAP5 column (GE Healthcare) pre-equilibrated with 10 ml PBS. The final dye/protein ratios (approximately2.4 for each) were determined using NanoDrop ND-100 spectrophotometer.
###end p 89
###begin title 90
###xml 19 22 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Crystallization of CAV-2 fiber head in complex with sialyl-lactose
###end title 90
###begin p 91
###xml 9 12 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Untagged CAV-2 fiber head was concentrated to 17 mg/ml in crystallization buffer (150 mM NaCl, 20 mM Tris pH 7.5, 8 mM sialyl-D-lactose) and crystallized in hanging drops containing 1 microl protein solution and 1 microl well solution (5% PEG 4000, 5% isopropanol, 0.1 M HEPES pH 7.4). Single crystals were transferred and frozen in a cryoprotectant solution (65% well solution, 25% glycerol, approximately 80 mM sialyl-D-lactose). The sialyl-D-lactose (Sigma) corresponds to alpha2-3 N-acetylneuraminosyl-D-lactose (according to the supplier).
###end p 91
###begin title 92
Purification and crystallization of fiber head complexes containing CAR D1 and sialyl-D-lactose
###end title 92
###begin p 93
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Seiradake1">[24]</xref>
###xml 57 60 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 363 366 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
The cloning, expression and crystallization of HAd37 and CAV-2 fiber head CAR D1 complexes (space groups I23 and I422) was performed as described previously [24]. After crystal growth, sialyl-D-lactose (Sigma) was added to the drop to a final concentration of 10 to 50 mM. Crystals were frozen the next day without adding cryoprotectant solution to crystals with CAV-2 fiber head complex, and with 20% glycerol in the crystallization condition for crystals with HAd37 fiber head complex.
###end p 93
###begin title 94
Data collection and processing
###end title 94
###begin p 95
###xml 167 175 167 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000277.s006">Table S1</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Kabsch1">[60]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-McCoy1">[61]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Murshudov1">[62]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Emsley1">[63]</xref>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Laskowski1">[64]</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Davis1">[65]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-DeLano1">[66]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Nicholls1">[67]</xref>
###xml 770 774 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Wallace1">[68]</xref>
###xml 864 868 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Galtier1">[69]</xref>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Gouet1">[70]</xref>
###xml 71 74 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 93 96 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 907 910 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 998 1001 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Details of the data collection and refinement of the three structures (CAV-2+sialyl-lactose, CAV-2+CAR D1+sialyl-lactose and HAd37+CAR D1+sialyl-lactose) are given in Table S1. All crystallographic data were collected at the European Synchrotron Radiation Facility (ESRF) and processed with XDS [60]. All structures were solved by molecular replacement using PHASER [61] and refined with REFMAC [62]. COOT [63] was used for the visualization of all models and electron density maps, and for the superposition of different models. PROCHECK [64] and MolProbity [65] were used for the validation of the obtained models. Representations of the protein models and the electron density were made with PYMOL [66] and GRASP [67]. Binding interfaces were visualized with DIMPLOT [68]. The structure-based sequence alignment was made with SARF, modified manually in SEAVIEW [69] and visualized with ESPript [70]. The CAV-2+sialyl-lactose structure contains two fiber head trimers in the asymmetric unit. The CAV-2+CAR D1+sialyl-lactose contains four trimeric fiber head - CAR D1 complexes in the asymmetric unit. Due to the modest resolution of this structure, NCS restraints and TLS refinement was used. The HAd37+CAR D1+sialyl-lactose structure has one fiber head monomer with bound CAR D1 in the asymmetric unit.
###end p 95
###begin title 96
Cloning and purification of HAd3 penton dodecahedra in complex with chimeric mini-fibers
###end title 96
###begin p 97
###xml 313 344 313 344 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AAT AAT CCA TGG CCA AGC GAG CTC</named-content>
###xml 349 384 349 384 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">nd GTT CCA TGC TAC CAA GGA TCC ATC </named-content>
###xml 480 515 480 515 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene"> were CTA CTG ATG GAT CCT TGG TAG C</named-content>
###xml 520 559 520 559 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">A AC and AAT AAT GAA TTC TCA TTC TTG GG</named-content>
###xml 645 684 645 684 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ing primers AAT AAT GAA TTC TCA TTC TTG</named-content>
###xml 689 720 689 720 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AAT ATA GG and AAT AAT CCA TGG </named-content>
###xml 1703 1706 1691 1694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Norrby1">[9]</xref>
###xml 1707 1711 1695 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Schoehn3">[71]</xref>
###xml 951 958 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 1460 1463 <span type="species:ncbi:12227?0.9375">TEV</span>
###xml 1566 1569 <span type="species:ncbi:12227?0.9375">TEV</span>
###xml 2251 2254 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Chimeric mini-fiber constructs were cloned by PCR in two steps. First, DNA fragments were produced using as template HAd3 genomic DNA (for fragment 1) or pPROEX HTb vectors coding for wild type or mutant HAd37 fiber head (for fragments 2 and 3). Fragment 1 coded for HAd3 tail and shaft motives 1+2 (primers were AAT AAT CCA TGG CCA AGC GAG CTC GG and GTT CCA TGC TAC CAA GGA TCC ATC AGT AG). Fragments 2 and 3 coded for wild type and mutant (K345E) HAd37 fiber head (primers used were CTA CTG ATG GAT CCT TGG TAG CAT GGA AC and AAT AAT GAA TTC TCA TTC TTG GGC AAT ATA GG). In a second PCR reaction, fragment 1 was annealed to fragment 2 or 3 using primers AAT AAT GAA TTC TCA TTC TTG GGC AAT ATA GG and AAT AAT CCA TGG CCA AGC GAG CTC GG. The resulting longer fragments coded for complete mini-fiber containing HAd3 tail+shaft and either wild type or mutant (K345E) HAd37 fiber head. These were cloned into pPROEX HTb, and expressed at 25degreesC in E. coli strain BL21 Star (DE3) (Life Technologies) together with an N-terminal cleavable 6xHis-tag. Cells were re-suspended in lysis buffer and sonicated. The cell lysate was centrifuged for 30 min at 25000g and the supernatant loaded on a Ni-NTA column (Qiagen). Protein bound to the resin was washed with 20 mM Tris-HCl pH 7.5, 300 mM NaCl, 50 mM imidazole and eluted in 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 500 mM imidazole. To remove the His-tag, mini-fibers were incubated overnight with 1/100 His-tagged TEV protease at 10degreesC. Imidazole was removed by dialysis against lysis buffer. Uncleaved protein and TEV protease were removed by binding to a Ni-NTA resin. HAd3 penton forms multimers (dodecahedra) consisting of twelve penton bases each [9],[71]. P. Fender (Institut de Biologie Structurale, Grenoble) generously supplied purified HAd3 dodecahedra. Mini-fibers and dodecahedra were mixed at an approximate molecular ratio of 1:10 and incubated at 4degreesC overnight. The mixture was loaded onto a Superdex200 column (Amersham) to remove excess fiber. The buffer contained 20 mM Tris pH7.5 and 300 mM NaCl. Dodecahedra in complex with mini-fiber were eluted with the void volume and were visualized with an electron microscope. All mini-fiber constructs carrying HAd3 tail+shaft and a CAV-2 fiber head were unstable, possibly because they were misfolded, or they did not bind to HAd3 dodecahedra.
###end p 97
###begin title 98
Flow cytometry
###end title 98
###begin p 99
###xml 298 304 <span type="species:ncbi:9986">rabbit</span>
###xml 394 400 <span type="species:ncbi:9986">rabbit</span>
###xml 420 423 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 554 560 <span type="species:ncbi:9986">rabbit</span>
Non-treated, mock-treated or neuraminidase-treated erythrocytes and non-tagged fiber heads were incubated for 20 min at 4degreesC. Cell samples serving as negative control were incubated with PBS instead of fiber head solution. The cells were pelleted at 800g, re-suspended in PBS containing 1:100 rabbit anti-HAd37 fiber head serum (gift from N. Arnberg, University of Umea) or 1:100 purified rabbit antibodies against CAV-2 fiber head, and incubated for 20 min at 4degreesC. The cells were pelleted as before, re-suspended in PBS containing 1:100 anti-rabbit FITC labeled antibody (Sigma) and incubated in the dark at 4degreesC for 20 min. The cells were pelleted again, re-suspended in PBS, and injected into a FACSCalibur apparatus (BD Biosciences). The results were analyzed using CellQuest and FlowJo software (BD Biosciences).
###end p 99
###begin title 100
Hemagglutination assays
###end title 100
###begin p 101
###xml 55 66 55 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pygerythrus</italic>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Asher1">[28]</xref>
###xml 583 607 579 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arthrobacter ureafaciens</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 7 10 <span type="species:ncbi:10116">rat</span>
###xml 21 24 <span type="species:ncbi:9615">dog</span>
###xml 43 66 <span type="species:ncbi:60710">Chlorocebus pygerythrus</span>
###xml 90 104 <span type="species:ncbi:9544">rhesus macaque</span>
###xml 106 116 <span type="species:ncbi:10141">guinea pig</span>
###xml 118 124 <span type="species:ncbi:9986">rabbit</span>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
###xml 406 411 <span type="species:ncbi:9606">human</span>
###xml 426 431 <span type="species:ncbi:10090">mouse</span>
###xml 583 607 <span type="species:ncbi:37931">Arthrobacter ureafaciens</span>
###xml 1017 1020 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Human, rat (Wistar), dog (beagle), vervet (Chlorocebus pygerythrus), cynomologous monkey, rhesus macaque, guinea pig, rabbit (New Zealand White), mouse (C57BL/6) or GATA1-CAR [28] mouse blood was collected in EDTA, heparin or Alsever's solution. Erythrocytes were purified using Ficol gradients, washed twice in PBS EDTA (5 min at 2000 rpm) and stored less than 48 hrs in PBS containing 5 mM EDTA. For the human and GATA1-CAR mouse erythrocytes two fractions of packed erythrocytes were re-suspended separately in neuraminidase buffer each. Neuraminidase alpha(2-3,-6,-8 and-9) from Arthrobacter ureafaciens (Sigma) or alpha(2-3,-6 and -8) (Ozyme) was activated as recommended, and added to one of the two erythrocytes fractions. Both mock- (without neuraminidase) and neuraminidase-containing fractions were incubated for 1 hr at 37degreesC. The cells were then washed 5 times with PBS to remove neuraminidase and buffer, and re-suspended in PBS containing 5 mM EDTA. Virus, dodecahedra +/- chimeric mini-fibers and CAV-2 fiber head multimers were diluted with PBS in 10-fold (in the first column) and then 2-fold (horizontal) steps and added to 96-well plates with cone-shaped bottoms. An equal number of purified erythrocytes (either non-treated, neuraminidase-treated, or mock-treated) was added to each well and incubated at room temperature or 37degreesC for at least 3 hrs. The blocking protein (approximately1 microg/well) was incubated with erythrocytes for 1 h at 4degreesC with slow rotation. All assays were repeated at least 3 times.
###end p 101
###begin title 102
Sedimentation with erythrocytes
###end title 102
###begin p 103
###xml 86 87 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 417 418 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
In a volume of 100 microl, CAVGFP or AdGFP (1 particle/cell) was incubated with 2.5x107 mock-treated or with neuraminidase-treated erythrocytes with PBS, or PBS supplemented with NaCl to bring its final concentration to 225 or 400 mM. The samples were incubated at room temperature for 15 min, and then centrifuged for 5 min at 5000 rpm in a microfuge. Aliquots of the supernatant were removed and incubated with 1x105 cells in 12-well plates. The cells were trypsinized and assayed for GFP expression by flow cytometry 24 hrs post-incubation. Data were analyzed using CellQuest. The assays were performed twice and in quadruplicate.
###end p 103
###begin title 104
Western blot
###end title 104
###begin p 105
###xml 67 68 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 361 362 331 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 175 180 <span type="species:ncbi:10090">mouse</span>
###xml 208 213 <span type="species:ncbi:9606">human</span>
###xml 678 684 <span type="species:ncbi:9986">rabbit</span>
###xml 789 795 <span type="species:ncbi:9986">rabbit</span>
Control cells and tissues were lysed with 100 microl SDS buffer (106 cells) and benzonase for 1 h at 37degreesC. The liver, peripheral blood mononuclear cells, NIH 3T3 cells (mouse fibroblasts) and 293 cell (human embryonic kidney) extracts (40 mg/ml) were resuspended in 100 microl of SDS-sample buffer. Erythrocytes (approximately200 microl) were lysed in ddH2O, the membranes were pellet for 10 min at 14,000 RPM in a microfuge and resuspended in 100 microl of SDS-sample buffer. SDS-PAGE was performed using a 5% acrylamide/bis-acrylamide stacking gel and a 12% acrylamide/bis-acrylamide running gel. Membranes were blocked with TBS-Tween, 10% milk at room temperature. The rabbit anti-CAR antibody CAR1605 was diluted 2000-fold for 1 h at RT in TBS-Tween 10% milk. The secondary anti-rabbit antibody was used at a dilution of 1/5000 for 30 min at room temperature in TBS-Tween 10% milk.
###end p 105
###begin title 106
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo injection of Ad vector
###end title 106
###begin p 107
###xml 76 78 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
Four adult GATA1-CAR and four control C57BL/6 mice were injected with 1.2x1011 pp of AdGFP via the tail vein. Blood (approximately100 microl) was taken by tail vein bleeds at 0.25, 6, 24 and 72 hr. The mice were sacrificed at 72 hr by lethal injection, and the organs were perfused with PBS via cardiac puncture. The liver, lung and spleen were recovered, divided into parts for qPCR or histology. The organs used for histology were fixed in 4% PFA for 24 hr then placed in 20% sucrose for 24 hr, and embedded in OCT matrix (CellPath, Powys, UK). Sections (10-microm-thick) were stained with 0.2 microg/ml bisBenzimide Hoechst (Sigma-Aldrich) and 1 ng/ml phalloidin-TRITC (Sigma-Aldrich) before being mounted. Images were acquired using a Zeiss microscope and processes using the MetaMorph (Molecular Devices, Wokingham, UK).
###end p 107
###begin title 108
Ethics
###end title 108
###begin p 109
The experimental protocols involving animals were approved by the University of Massachusetts Medical School Institutional Animal Care and Use Committee.
###end p 109
###begin title 110
Quantitative PCR
###end title 110
###begin p 111
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000277-Lutfalla1">[72]</xref>
###xml 311 338 311 338 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACA GTC CAT GCC ATC ACT GCC</named-content>
###xml 361 388 361 388 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCC TGC TTC ACC ACC TTC TTG</named-content>
###xml 419 442 419 442 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CAG AAG AAC GGC ATC AAG</named-content>
###xml 464 487 464 487 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CTG GGT GCT CAG GTA </named-content>
Total DNA from blood and liver were extracted by using the High Pure DNA Isolation kit (Roche Diagnostics). qPCR was performed with a Light Cycler (Roche Diagnostics) using the Platinum Taq DNA polymerase (Invitrogen) and SYBR Green qPCR master mix [72]. The primer pairs used for GAPDH were: GAPDH forward, 5' ACA GTC CAT GCC ATC ACT GCC 3'; GAPDH reverse, 5' GCC TGC TTC ACC ACC TTC TTG 3'; and the EGFP: forward, 5' CAG AAG AAC GGC ATC AAG GT 3'; eGFP reverse, 5' CTG GGT GCT CAG GTA GTG G 3'. Data are expressed as a ratio of GAPDH to EGFP.
###end p 111
###begin title 112
Statistical analysis
###end title 112
###begin p 113
###xml 45 53 45 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Data were analyzed using a one-way ANOVA and post-hoc comparisons were made using an unpaired Student's t-test.
###end p 113
###begin title 114
Supporting Information
###end title 114
###begin p 115
Electron micrographs of dodecahedra +/- fiber. A) Ad3 penton dodecahedra B) Ad3 penton dodecahedra in complex with chimeric minifiber containing wild type HAd37 fiber head. To the right of the photos are computer generated models of the structures. Below are enlarged images of the dodecahedra +/- fiber.
###end p 115
###begin p 116
(1.11 MB TIF)
###end p 116
###begin p 117
Click here for additional data file.
###end p 117
###begin p 118
###xml 47 52 <span type="species:ncbi:9606">human</span>
Binding of wild type and mutant fiber heads to human erythrocytes. A) SPR curves obtained with different concentrations of wild type HAd37 fiber head (HAd37Hwt) and immobilized glycophorin (GP). B) SPR curves obtained with HAd37Hwt and mutant HAd37 fiber heads (HAd37HSA-1 and HAd37HSA-2) at 2 microM and immobilized GP. C) SPR curves obtained with HAd37Hwt and mutant HAd37 fiber heads at 2 microM and immobilized asialoGP.
###end p 118
###begin p 119
(0.27 MB TIF)
###end p 119
###begin p 120
Click here for additional data file.
###end p 120
###begin p 121
###xml 16 19 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
###xml 93 96 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Sequence of the CAV-2 and HAd37 fiber heads. Structure based sequence alignment of HAd37 and CAV-2 fiber heads. Residues forming hydrogen bonds with sialic acid are highlighted with a blue background; residues involved in hydrophobic contacts with sialic acid are highlighted with yellow background; residues providing both types of contacts are highlighted in blue and yellow.
###end p 121
###begin p 122
(0.99 MB TIF)
###end p 122
###begin p 123
Click here for additional data file.
###end p 123
###begin p 124
Flow chart showing competition-based agglutination assays.
###end p 124
###begin p 125
(1.87 MB TIF)
###end p 125
###begin p 126
Click here for additional data file.
###end p 126
###begin p 127
Relative agglutination with erythrocytes from different species.
###end p 127
###begin p 128
(0.10 MB TIF)
###end p 128
###begin p 129
Click here for additional data file.
###end p 129
###begin p 130
Summary of data collection and refinement statistics.
###end p 130
###begin p 131
(0.09 MB DOC)
###end p 131
###begin p 132
Click here for additional data file.
###end p 132
###begin p 133
We thank N. Arnberg for HAd37 and antiserum, S. Hemmi, J. Zabner and S. Carson for the anti-CAR antibodies, and P. Boulanger and W. Burmeister for advice. We thank EMBL and ESRF staff for help on synchrotron beam lines ID14-EH4 and ID29. We thank C. Cazevieille, CRIC Montpellier for the help with the SEM photo of the agglutinated cells.
###end p 133
###begin title 134
References
###end title 134
###begin article-title 135
Adenovirus complex structures.
###end article-title 135
###begin article-title 136
The fibers of fowl adenoviruses.
###end article-title 136
###begin article-title 137
Adenovirus receptors.
###end article-title 137
###begin article-title 138
###xml 0 18 <span type="species:ncbi:10524">Adenovirus type 41</span>
Adenovirus type 41 lacks an RGD alpha(v)-integrin binding motif on the penton base and undergoes delayed uptake in A549 cells.
###end article-title 138
###begin article-title 139
###xml 0 24 <span type="species:ncbi:10514">Canine adenovirus type 2</span>
Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway.
###end article-title 139
###begin article-title 140
Clinical features and treatment of adenovirus infections.
###end article-title 140
###begin article-title 141
Adenoviruses in the immunocompromised host.
###end article-title 141
###begin article-title 142
Hemagglutination by adenoviruses.
###end article-title 142
###begin article-title 143
###xml 43 60 <span type="species:ncbi:10527">adenovirus type 9</span>
Separation and characterization of soluble adenovirus type 9 components.
###end article-title 143
###begin article-title 144
Hemagglutination with adenovirus serotypes belonging to Rosen's subgroups II and 3.
###end article-title 144
###begin article-title 145
###xml 59 76 <span type="species:ncbi:10534">adenovirus type 6</span>
Fiber-associated incomplete and complete hemagglutinins of adenovirus type 6.
###end article-title 145
###begin article-title 146
###xml 22 39 <span type="species:ncbi:10537">canine adenovirus</span>
Characterization of a canine adenovirus hemagglutinin.
###end article-title 146
###begin article-title 147
Red blood cell glycophorins.
###end article-title 147
###begin article-title 148
###xml 0 8 <span type="species:ncbi:10891">Reovirus</span>
Reovirus receptors and pathogenesis.
###end article-title 148
###begin article-title 149
Glycoconjugate glycans as viral receptors.
###end article-title 149
###begin article-title 150
###xml 10 18 <span type="species:ncbi:10629">BK virus</span>
Update on BK virus entry and intracellular trafficking.
###end article-title 150
###begin article-title 151
Role of sialic acids in rotavirus infection.
###end article-title 151
###begin article-title 152
Sialic acids as receptor determinants for coronaviruses.
###end article-title 152
###begin article-title 153
###xml 25 30 <span type="species:ncbi:9606">human</span>
Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.
###end article-title 153
###begin article-title 154
Epitopes and hemagglutination binding domain on subgenus B:2 adenovirus fibers.
###end article-title 154
###begin article-title 155
###xml 30 35 <span type="species:ncbi:9606">human</span>
Recombinant fiber proteins of human adenoviruses Ad9, Ad15 and Ad19: localization of the haemagglutination properties and the type-specific determinant.
###end article-title 155
###begin article-title 156
Molecular characterization of the type-specific gamma-determinant located on the adenovirus fiber.
###end article-title 156
###begin article-title 157
Molecular characterization of hemagglutination domains on the fibers of subgenus D adenoviruses.
###end article-title 157
###begin article-title 158
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 53 72 <span type="species:ncbi:10514">canine adenovirus 2</span>
Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor.
###end article-title 158
###begin article-title 159
###xml 0 18 <span type="species:ncbi:52275">Adenovirus type 37</span>
Adenovirus type 37 uses sialic acid as a cellular receptor.
###end article-title 159
###begin article-title 160
Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis.
###end article-title 160
###begin article-title 161
Crystal structure of species D adenovirus fiber knobs and their sialic acid binding sites.
###end article-title 161
###begin article-title 162
The erythrocyte viral trap: transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection.
###end article-title 162
###begin article-title 163
Titer determination of Ad5 in blood: a cautionary note.
###end article-title 163
###begin article-title 164
Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions.
###end article-title 164
###begin article-title 165
###xml 56 80 <span type="species:ncbi:10514">canine adenovirus type 2</span>
An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism.
###end article-title 165
###begin article-title 166
###xml 31 48 <span type="species:ncbi:10537">canine adenovirus</span>
Three-dimensional structure of canine adenovirus serotype 2 capsid.
###end article-title 166
###begin article-title 167
###xml 0 18 <span type="species:ncbi:52275">Adenovirus type 37</span>
Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction.
###end article-title 167
###begin article-title 168
###xml 0 17 <span type="species:ncbi:28285">Adenovirus type 5</span>
###xml 36 41 <span type="species:ncbi:9606">human</span>
Adenovirus type 5 interactions with human blood cells may compromise systemic delivery.
###end article-title 168
###begin article-title 169
Crystal structure of enteric adenovirus serotype 41 short fiber head.
###end article-title 169
###begin article-title 170
###xml 85 89 <span type="species:ncbi:10116">rats</span>
Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats.
###end article-title 170
###begin article-title 171
The coxsackievirus and adenovirus receptor.
###end article-title 171
###begin article-title 172
Alpha4beta1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development.
###end article-title 172
###begin article-title 173
Adenovirus serotype 5 hexon mediates liver gene transfer.
###end article-title 173
###begin article-title 174
Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape.
###end article-title 174
###begin article-title 175
Rodent nonclinical safety evaluation studies of SCH 58500, an adenoviral vector for the p53 gene.
###end article-title 175
###begin article-title 176
###xml 88 95 <span type="species:ncbi:9606">patient</span>
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.
###end article-title 176
###begin article-title 177
###xml 47 64 <span type="species:ncbi:10537">canine adenovirus</span>
###xml 77 85 <span type="species:ncbi:9654">raccoons</span>
Oral administration of an attenuated strain of canine adenovirus (type 2) to raccoons, foxes, skunk, and mongoose.
###end article-title 177
###begin article-title 178
###xml 22 34 <span type="species:ncbi:9646">giant pandas</span>
###xml 36 58 <span type="species:ncbi:9646">Ailuropoda melanoleuca</span>
###xml 64 74 <span type="species:ncbi:9649">red pandas</span>
###xml 76 91 <span type="species:ncbi:9649">Ailurus fulgens</span>
Serosurvey of ex situ giant pandas (Ailuropoda melanoleuca) and red pandas (Ailurus fulgens) in China with implications for species conservation.
###end article-title 178
###begin article-title 179
###xml 70 83 <span type="species:ncbi:9644">grizzly bears</span>
###xml 85 108 <span type="species:ncbi:116960">Ursus arctos horribilis</span>
###xml 127 143 <span type="species:ncbi:9643">Ursus americanus</span>
Serological survey of selected canine viral pathogens and zoonoses in grizzly bears (Ursus arctos horribilis) and black bears (Ursus americanus) from Alaska.
###end article-title 179
###begin article-title 180
Virus receptors: binding, adhesion strengthening, and changes in viral structure.
###end article-title 180
###begin article-title 181
###xml 13 30 <span type="species:ncbi:10537">canine adenovirus</span>
CAR chasing: canine adenovirus vectors-all bite and no bark?
###end article-title 181
###begin article-title 182
Gene transfer to the central nervous system: current state of the art of the viral vectors.
###end article-title 182
###begin article-title 183
###xml 40 57 <span type="species:ncbi:10537">canine adenovirus</span>
Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo.
###end article-title 183
###begin article-title 184
###xml 57 60 <span type="species:ncbi:10116">rat</span>
###xml 113 116 <span type="species:ncbi:10537?0.03374233128834356">CAV</span>
Long-term in vivo transduction of neurons throughout the rat central nervous system using novel helper-dependent CAV-2 vectors.
###end article-title 184
###begin article-title 185
[Properties of Adenovirus Hemagglutinins.].
###end article-title 185
###begin article-title 186
Virus-erythrocyte interactions.
###end article-title 186
###begin article-title 187
Studies on adenovirus receptors on red cells.
###end article-title 187
###begin article-title 188
###xml 26 29 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 39 52 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 54 68 <span type="species:ncbi:9544">Macaca mulatta</span>
Adenoviral hepatitis in a SIV-infected rhesus monkey (Macaca mulatta).
###end article-title 188
###begin article-title 189
Adenovirus-associated acute respiratory disease in healthy adolescents and adults: a literature review.
###end article-title 189
###begin article-title 190
Severe Pneumonia Due to Adenovirus Serotype 14: A New Respiratory Threat?
###end article-title 190
###begin article-title 191
###xml 0 17 <span type="species:ncbi:10537">Canine adenovirus</span>
Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer.
###end article-title 191
###begin article-title 192
###xml 21 38 <span type="species:ncbi:10537">canine adenovirus</span>
Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein.
###end article-title 192
###begin article-title 193
An archaeal peptidase assembles into two different quaternary structures: A tetrahedron and a giant octahedron.
###end article-title 193
###begin article-title 194
Moving median filters for area-detector data.
###end article-title 194
###begin article-title 195
Likelihood-enhanced fast translation functions.
###end article-title 195
###begin article-title 196
Efficient anisotropic refinement of macromolecular structures using FFT.
###end article-title 196
###begin article-title 197
Coot: model-building tools for molecular graphics.
###end article-title 197
###begin article-title 198
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR.
###end article-title 198
###begin article-title 199
MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes.
###end article-title 199
###begin article-title 200
High b-value diffusion imaging.
###end article-title 200
###begin article-title 201
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.
###end article-title 201
###begin article-title 202
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.
###end article-title 202
###begin article-title 203
SEAVIEW and PHYLO_WIN: two graphic tools for sequence alignment and molecular phylogeny.
###end article-title 203
###begin article-title 204
ESPript: analysis of multiple sequence alignments in PostScript.
###end article-title 204
###begin article-title 205
Adenovirus 3 penton dodecahedron exhibits structural changes of the base on fiber binding.
###end article-title 205
###begin article-title 206
Performing quantitative reverse-transcribed polymerase chain reaction experiments.
###end article-title 206
###begin p 207
The authors have declared that no competing interests exist.
###end p 207
###begin p 208
ES was supported by an "E-STAR" fellowship funded by the EU FP6 Marie Curie Host fellowship for Early Stage Research Training under contract number MEST-CT-2004-504640. GS was supported in part by a Jeunes Chercheurs grant from the Agence Nationale pour la Recherche. HW, VK and EJK are Inserm fellows. Part of this work was funded by the Association Francaise contre les Myopathies (12008) (EJK), Vaincre les Maladies Lysosomales (EJK), Region Languedoc Roussillon (EJK), Vaincre la Mucoviscidose (EJK), the Fondation pour la Recherche Medicale (EJK) and an EC FP7 contract 222922 (BrainCAV).
###end p 208

